Jessica Sachs - Dec 31, 2021 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Medical Officer
Signature
/s/ Ryan Murr, Attorney-in-Fact
Stock symbol
COGT
Transactions as of
Dec 31, 2021
Transactions value $
$4,595
Form type
4
Date filed
1/4/2022, 08:25 PM
Next filing
Jan 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COGT Common Stock Award $4.59K +674 $6.82 674 Dec 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).